{"transactions":[{"id":737686,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-15T21:23:23.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":38040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 12, 2026."}],"balance_after":38040,"derivative":{"exercise_price":4.16,"expiration_date":"2036-06-12","underlying":"Common Stock","underlying_shares":38040},"source":{"system":"sec-edgar","filing":"0001654482-26-000003","document":"form4-06152026_090619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000165448226000003/form4-06152026_090619.xml","form_type":"4"}},{"id":1109690,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T20:58:37.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":40006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 12, 2025."}],"balance_after":40006,"derivative":{"exercise_price":2.04,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":40006},"source":{"system":"sec-edgar","filing":"0001415889-25-017412","document":"form4-06162025_080632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925017412/form4-06162025_080632.xml","form_type":"4"}},{"id":1478853,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:10:18.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":45832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 12, 2024."}],"balance_after":45832,"derivative":{"exercise_price":1.7,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45832},"source":{"system":"sec-edgar","filing":"0001415889-24-016872","document":"form4-06142024_080614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924016872/form4-06142024_080614.xml","form_type":"4"}},{"id":1935648,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-29T20:20:41.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":59206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares  subject to option shall be fully vested on the three year anniversary of the grant date. The grant date is March 27, 2023."}],"balance_after":59206,"derivative":{"exercise_price":7.25,"expiration_date":"2033-03-27","underlying":"Common Stock","underlying_shares":59206},"source":{"system":"sec-edgar","filing":"0001209191-23-021531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919123021531/doc4.xml","form_type":"4"}},{"id":2180767,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T16:26:11.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":68367,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":37.68,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":68367},"source":{"system":"sec-edgar","filing":"0001209191-22-046264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122046264/doc4.xml","form_type":"4"}},{"id":2180766,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T16:26:11.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":29175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option with an exercise price equal to or greater than $76.00, was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option with an exercise price equal to or greater than $76.00, was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":140.01,"expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":29175},"source":{"system":"sec-edgar","filing":"0001209191-22-046264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122046264/doc4.xml","form_type":"4"}},{"id":2180765,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T16:26:11.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":169192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":54.73,"expiration_date":"2029-12-01","underlying":"Common Stock","underlying_shares":169192},"source":{"system":"sec-edgar","filing":"0001209191-22-046264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122046264/doc4.xml","form_type":"4"}},{"id":2180764,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-08-17T16:26:11.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":41284,"price":76,"value":3137584.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 2, 2022, by and among Turning Point Therapeutics, Inc. (the \"Issuer\"), Bristol-Myers Squibb Company (\"BMS\") and Rhumba Merger Sub Inc., a wholly owned subsidiary of BMS (\"Purchaser\"), on August 17, 2022, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of BMS (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for $76.00 per Share in cash, without interest, subject to any applicable withholding of taxes (the \"Cash Amount\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Cash Amount."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding restricted stock unit award (\"RSU\") whether vested or unvested was cancelled and converted into the right to receive cash, without interest, in an amount equal to $76.00 per Share issuable in settlement of such RSU immediately before the effective time of the Merger, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 463 shares acquired on June 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-046264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122046264/doc4.xml","form_type":"4"}},{"id":2400942,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T18:08:52.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":68367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares vest monthly following February 9, 2022."}],"balance_after":68367,"derivative":{"exercise_price":37.68,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":68367},"source":{"system":"sec-edgar","filing":"0001209191-22-008980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008980/doc4.xml","form_type":"4"}},{"id":2400941,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-11T18:08:52.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan."}],"balance_after":40821,"source":{"system":"sec-edgar","filing":"0001209191-22-008980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008980/doc4.xml","form_type":"4"}},{"id":2400940,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-11T18:08:52.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":18983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan."}],"balance_after":25821,"source":{"system":"sec-edgar","filing":"0001209191-22-008980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008980/doc4.xml","form_type":"4"}},{"id":2400939,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-11T18:08:52.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":669,"price":36.3,"value":24284.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 301 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the \"ESPP\") and 439 shares on December 10, 2021 pursuant to the ESPP."}],"balance_after":6838,"source":{"system":"sec-edgar","filing":"0001209191-22-008980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008980/doc4.xml","form_type":"4"}},{"id":2868516,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right  to buy)","published_at":"2021-02-10T18:03:05.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":29175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares vest monthly following February 8, 2021."}],"balance_after":29175,"derivative":{"exercise_price":140.01,"expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":29175},"source":{"system":"sec-edgar","filing":"0001209191-21-009378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121009378/doc4.xml","form_type":"4"}},{"id":2868515,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-10T18:03:05.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":6483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001209191-21-009378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121009378/doc4.xml","form_type":"4"}},{"id":2918763,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":1253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vest on December 2, 2020 and 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":169192,"derivative":{"exercise_price":54.73,"expiration_date":"2029-12-01","underlying":"Common Stock","underlying_shares":1253},"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":2918762,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":8747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vest on December 2, 2020 and 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":170445,"derivative":{"exercise_price":54.73,"expiration_date":"2029-12-01","underlying":"Common Stock","underlying_shares":8747},"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":2918761,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":1253,"price":120,"value":150360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."}],"balance_after":284,"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":2918760,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":1253,"price":54.73,"value":68576.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."}],"balance_after":1537,"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":2918759,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":8747,"price":120.42,"value":1053313.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $120.42, and the range of prices were between $120.00 and $121.00.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":284,"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":2918758,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":300,"price":122.44,"value":36732.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."}],"balance_after":9031,"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":2918757,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:03:46.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":8747,"price":54.73,"value":478723.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 300 shares on June 12, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the \"ESPP\") and 284 shares on December 10, 2020 pursuant the ESPP."}],"balance_after":9331,"source":{"system":"sec-edgar","filing":"0001209191-21-001724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121001724/doc4.xml","form_type":"4"}},{"id":3353642,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-03T16:49:22.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":179192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on December 2, 2020 and 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":179192,"derivative":{"exercise_price":54.73,"expiration_date":"2029-12-01","underlying":"Common Stock","underlying_shares":179192},"source":{"system":"sec-edgar","filing":"0001209191-19-058729","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919119058729/doc4.xml","form_type":"4"}},{"id":4592118,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Appreciation Rights","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":58800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This stock appreciation right (the \"SAR\") was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share base price of the SAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock appreciation right (the \"SAR\") was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share base price of the SAR."}],"balance_after":0,"derivative":{"exercise_price":11.5975,"expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":58800},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592117,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":14474,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The number of shares subject to the performance-based restricted stock unit (the \"PSUs\") is based on deemed satisfaction of all applicable performance goals at the maximum levels."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The PSUs were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such PSUs, converted into the right to receive cash payment equal to $81.50 per share (without interest)subject to any required withholding of taxes. In connection with the Merger, vesting of the PSUs was accelerated and the PSUs became fully vested effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The PSUs were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such PSUs, converted into the right to receive cash payment equal to $81.50 per share (without interest)subject to any required withholding of taxes. In connection with the Merger, vesting of the PSUs was accelerated and the PSUs became fully vested effective immediately prior to the effective time of the Merger."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The number of shares subject to the performance-based restricted stock unit (the \"PSUs\") is based on deemed satisfaction of all applicable performance goals at the maximum levels."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":14474},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592116,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":1120,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":46.45,"expiration_date":"2026-04-08","underlying":"Common Stock","underlying_shares":1120},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592115,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":38530,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":35.77,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":38530},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592114,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":2380,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":42.5,"expiration_date":"2025-09-30","underlying":"Common Stock","underlying_shares":2380},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592113,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":13560,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":60.525,"expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":13560},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592112,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":3460,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":52.85,"expiration_date":"2024-10-31","underlying":"Common Stock","underlying_shares":3460},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592111,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":11740,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":35.955,"expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":11740},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592110,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":16880,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":27.43,"expiration_date":"2022-12-17","underlying":"Common Stock","underlying_shares":16880},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592109,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":3.7925,"expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592108,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":8.64,"expiration_date":"2019-12-15","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592107,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":18684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents unvested restricted stock units (the \"RSUs\") that were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such RSUs, converted into the right to receive cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes.  In connection with the Merger, vesting of the RSUs was accelerated and the RSUs became fully vested effective immediately prior to the effective time of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4592106,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-30T17:44:03.000Z","date":"2016-09-28","kind":"other","acquired":false,"shares":39068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 229 shares purchased through the Issuer's Employee Stock Purchase Plan on September 21, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-143378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143378/doc4.xml","form_type":"4"}},{"id":4600537,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-19T16:50:45.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.6925,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001209191-16-142002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116142002/doc4.xml","form_type":"4"}},{"id":4600536,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-19T16:50:45.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":5620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.0025,"expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":5620},"source":{"system":"sec-edgar","filing":"0001209191-16-142002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116142002/doc4.xml","form_type":"4"}},{"id":4600535,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-19T16:50:45.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":11940,"price":4.6925,"value":56028.45,"ownership":{"direct":true},"balance_after":57523,"source":{"system":"sec-edgar","filing":"0001209191-16-142002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116142002/doc4.xml","form_type":"4"}},{"id":4600534,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":38132,"kind":"person","name":"Hirmand Mohammad","position":1,"cik":"0001654482","reported_name":"Hirmand Mohammad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-19T16:50:45.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":5620,"price":4.0025,"value":22494.05,"ownership":{"direct":true},"balance_after":45583,"source":{"system":"sec-edgar","filing":"0001209191-16-142002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116142002/doc4.xml","form_type":"4"}}]}